Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00414765
Status:
COMPLETED
Last Update Posted:
2021-06-08
First Post:
2006-12-21
Brief Title:
Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2010-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-21
First Submit QC Date:
December 21 2006
Study First Post Date:
2006-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-06-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-02-09
Disp First Submit QC Date:
February 9 2013
Disp First Post Date:
2013-02-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-06-04
Last Update Post Date:
2021-06-08
Last Update Post Date Type:
ACTUAL